论文部分内容阅读
目的:分析比较红霉素与阿奇霉素治疗支原体肺炎的临床效果,给临床治疗提供理论依据。方法:选取2015年2月-2016年2月在医院接受治疗的78例支原体肺炎患者作为研究对象,按照患者入院的先后顺序将患者平均分成两组,对照组应用红霉素治疗;观察组应用阿奇霉素治疗,分析比较两组患者的治疗效果。结果:观察组总有效率为97.37%;对照组总有效率为86.84%,观察组的有效率明显高于对照组,组间差异具有统计学意义(P<0.05);观察组不良反应发生率为31.58%;对照组不良反应发生率为52.63%.对照组中胃肠道反应发生率和不良反应发生率明显低于对照组,组间差异显著,具有统计学意义(P<0.05)。结论:阿奇霉素治疗支原体肺炎感染疗效明显,不良反应发生率低,值得临床推广使用。
Objective: To analyze the clinical effects of erythromycin and azithromycin in the treatment of mycoplasma pneumonia, and to provide a theoretical basis for clinical treatment. Methods: A total of 78 patients with mycoplasma pneumonia who were treated in the hospital from February 2015 to February 2016 were selected as the study subjects. Patients were equally divided into two groups according to the sequence of hospital admission. The control group was treated with erythromycin. The observation group Azithromycin treatment, analysis and treatment of two groups of patients. Results: The total effective rate in the observation group was 97.37%; the total effective rate in the control group was 86.84%; the effective rate in the observation group was significantly higher than that in the control group (P <0.05); the incidence of adverse reactions in the observation group (31.58%). The incidence of adverse reactions in the control group was 52.63%. The incidence of gastrointestinal reactions and adverse reactions in the control group were significantly lower than those in the control group, with significant difference between the two groups (P <0.05). Conclusion: Azithromycin treatment of mycoplasma pneumonia infection obvious effect, the incidence of adverse reactions is low, worthy of clinical promotion and use.